CEREBRAL CAPILLARY TELANGIECTASIA

This adverse event was reported 4 times

These drugs are most commonly taken by patients reporting CEREBRAL CAPILLARY TELANGIECTASIA:

# Drug Count
0 ADALIMUMAB 1
1 CANDESARTAN CILEXETIL 1
2 CERITINIB 1
3 METOCLOPRAMIDE 1
4 METOCLOPRAMIDE HYDROCHLORIDE 1
5 RANITIDINE 1
6 SOMATROPIN 1
7 UPADACITINIB 1
See all common drugs associated with CEREBRAL CAPILLARY TELANGIECTASIA

CEREBRAL CAPILLARY TELANGIECTASIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CERITINIB 1 0.0004
1 CANDESARTAN CILEXETIL 1 0.0000
2 SOMATROPIN 1 0.0000
3 METOCLOPRAMIDE HYDROCHLORIDE 1 0.0000
4 UPADACITINIB 1 0.0000
5 RANITIDINE 1 0.0000
6 ADALIMUMAB 1 0.0000
See all drugs enriched for association with CEREBRAL CAPILLARY TELANGIECTASIA

These drug classes are most commonly taken by patients reporting CEREBRAL CAPILLARY TELANGIECTASIA:

# Drug class Count
0 Janus Kinase Inhibitor [EPC] 1
1 Recombinant Human Growth Hormone [EPC] 1
See all common drug classes associated with CEREBRAL CAPILLARY TELANGIECTASIA

CEREBRAL CAPILLARY TELANGIECTASIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Recombinant Human Growth Hormone [EPC] 1 0.0000
1 Janus Kinase Inhibitor [EPC] 1 0.0000
See all drug classes enriched for association with CEREBRAL CAPILLARY TELANGIECTASIA